Digital health companies are producing increasingly innovative products at a rapidly accelerating pace, fueled in large part by the expansive healthcare data ecosystem and the data strategies for harnessing the power of that...more
On January 7, 2020, the Director of the US Office of Management and Budget (OMB) issued a Draft Memorandum (the Memorandum) to all federal “implementing agencies” regarding the development of regulatory and non-regulatory...more
1/20/2020
/ 21st Century Cures Act ,
Artificial Intelligence ,
Big Data ,
Data Privacy ,
Food and Drug Administration (FDA) ,
Government Agencies ,
Machine Learning ,
Medical Devices ,
OMB ,
Policy Memorandums ,
Regulatory Agenda ,
Technology ,
Telehealth
On January 7, 2020, the Director of the US Office of Management and Budget (OMB) issued a Draft Memorandum (the Memorandum) to all federal “implementing agencies” regarding the development of regulatory and non-regulatory...more
1/16/2020
/ 21st Century Cures Act ,
Artificial Intelligence ,
Big Data ,
Data Privacy ,
Federal Grants ,
Food and Drug Administration (FDA) ,
Medical Devices ,
OMB ,
Policy Memorandums ,
Public Agencies ,
Public Interest ,
Regulatory Agencies ,
Regulatory Agenda ,
Risk Assessment ,
Risk Management ,
Technology ,
Telehealth ,
White Papers
Introduction -
Throughout 2017, the health care and life science industries experienced a widespread proliferation of digital health innovation that presents challenges to traditional notions of health care delivery and...more
1/10/2018
/ 21st Century Cures Act ,
Artificial Intelligence ,
Biometric Information ,
Consumer Protection Act ,
Cyber Threats ,
Cybersecurity ,
Data Breach ,
Department of Health and Human Services (HHS) ,
Digital Health ,
Federal Trade Commission (FTC) ,
Food and Drug Administration (FDA) ,
Health Information Technologies ,
Health Insurance ,
Life Sciences ,
OIG ,
Privacy Policy ,
Research and Development ,
TCPA ,
Telehealth